Although sufficient cholesterol supply is known to be crucial for neurons in the developing mammalian brain, the cholesterol requirement of neural stem and progenitor cells in the embryonic central nervous system has not been addressed. Here we have conditionally ablated the activity of squalene synthase (SQS), a key enzyme for endogenous cholesterol production, in the neural stem and progenitor cells of the ventricular zone (VZ) of the embryonic mouse brain. Mutant embryos exhibited a reduced brain size due to the atrophy of the neuronal layers, and died at birth. Analyses of the E11.5-E15.5 dorsal telencephalon and diencephalon revealed that this atrophy was due to massive apoptosis of newborn neurons, implying that this progeny of the SQS-ablated neural stem and progenitor cells was dependent on endogenous cholesterol biosynthesis for survival. Interestingly, the neural stem and progenitor cells of the VZ, the primary target of SQS inactivation, did not undergo significant apoptosis. Instead, vascular endothelial growth factor (VEGF) expression in these cells was strongly upregulated via a hypoxia-inducible factor-1-independent pathway, and angiogenesis in the VZ was increased. Consistent with an increased supply of lipoproteins to these cells, the level of lipid droplets containing triacylglycerides with unsaturated fatty acyl chains was found to be elevated. Our study establishes a direct link between intracellular cholesterol levels, VEGF expression, and angiogenesis. Moreover, our data reveal a hitherto unknown compensatory process by which the neural stem and progenitor cells of the developing mammalian brain evade the detrimental consequences of impaired endogenous cholesterol biosynthesis.
C
holesterol is a key lipid constituent of post-Golgi membranes of mammalian cells, notably the plasma membrane. Together with sphingolipids, cholesterol forms lateral membrane lipid assemblies called ''lipid rafts'' that interact with ''raftophilic'' membrane proteins to generate specific cholesterol-based membrane microdomains. The latter have important roles in cell functions, such as membrane traffic and signal transduction (1) (2) (3) .
Not surprisingly in light of their highly elaborate morphology, neurons have been shown to possess distinct cholesterol-based plasma membrane microdomains (4) (5) (6) (7) . Accordingly, neuronal differentiation, in particular synaptogenesis, is a cholesteroldependent process (8, 9) . However, the cholesterol requirement of the neural stem and progenitor cells that give rise to neurons during the development of the mammalian CNS is unclear.
There are various reasons to suspect that neural stem and progenitor cells may be sensitive to a lack of cholesterol. Interference with cholesterol biosynthesis leads to massive defects in CNS development that appear even before the onset of neurogenesis (10) . Moreover, an apical plasma membrane protein of the neural stem and progenitor cells lining the lumen of the neural tube [i.e., the ventricular zone (VZ) progenitors], prominin-1 (CD133) (11) , directly interacts with membrane cholesterol and is a key constituent of a cholesterol-based plasma membrane microdomain (12) . These microdomains are released from VZ progenitor cell-surface protrusions as membrane vesicles into the neural tube fluid, a developmentally regulated process that is promoted by cholesterol depletion (13) (14) (15) .
Like other cells, VZ progenitor cells as well as the neurons derived therefrom have 2 principal sources of cholesterol: endogenous biosynthesis and external supply. Here we have conditionally ablated cholesterol biosynthesis in VZ progenitors of the mouse embryo and investigated the consequences for brain development. Surprisingly, we find that VZ progenitors protect themselves against cholesterol deprivation by upregulating the expression of VEGF, thereby raising their supply with cholesterol via increased angiogenesis in the VZ, whereas newborn neurons derived from the VZ progenitors undergo apoptosis, resulting in a smaller brain and lethality at birth.
Results

Conditional SQS Ablation in VZ Progenitors Using nestin-Cre Results in
Reduced Size and Altered Structure of the Embryonic Mouse Brain. To specifically ablate cholesterol biosynthesis, we focused on squalene synthase (SQS, also called Fdft1), the enzyme catalyzing the first metabolic step in the cholesterol biosynthetic pathway that is exclusively committed to sterol biosynthesis. A mouse line carrying a floxed SQS allele (16) allows the Cremediated deletion of exon 5, which encodes the catalytic center. To selectively ablate cholesterol biosynthesis in the neural stem and progenitor cells of the VZ, we crossed SQS flox/flox mice with a transgenic mouse line expressing the Cre recombinase under the control of the rat nestin promoter and enhancer (17) , which is known to mediate deletion of floxed genes in VZ progenitors of the developing brain as early as embryonic day 10.5 (E10.5) (18) (see also Fig. 3A below) . The resulting, conditionally SQS-ablated (SQS-cKO) embr yos and newborn pups (SQS flox/flox /nestin-Cre ϩ/Ϫ ) were obtained with normal Mendelian frequency [supporting information (SI) Table S1 ]. However, mutant pups died at birth (postnatal day 0, P0), without their lungs becoming inflated (data not shown), indicating their inability to breathe. Gross morphology of the SQS-cKO embryos and newborn pups was similar to that of control littermates ( Fig. 1 A-F ) . However, at E16.5 and at P0, the dissected brains of SQS-cKO mice exhibited an overt reduction in size when compared with control littermates, which was not yet obvious at E13.5 ( Fig. 1 A'-F') .
Nonetheless, as early as E13.5 the SQS-cKO brain showed subtle changes in structure when examined by DAPI staining of coronal cryosections. The most noticeable defect was a reduction in the radial thickness of the diencephalon (DiE) (data not shown). At E15.5 the SQS-cKO brain showed additional structural alterations, notably in the telencephalon, where a reduction in the size of the ganglionic eminences and in the radial thickness of the cortical wall was observed ( Fig. 1 G and H) .
SQS Inactivation in VZ Progenitors Results in Apoptosis Predominantly
of Young Neurons. We next investigated the reason underlying the reduction in the radial thickness of the cortical wall and DiE. To distinguish between the progenitor-containing and the neuronenriched layers, we performed immunostaining for ␤-III-tubulin (TUJ1), a marker of young neurons (19) . This revealed a reduction in the radial thickness of the neuronal layers (NL) that was detectable for the DiE at E13. 5 but not yet at E12.5, and for the dorsal telencephalon (dTE) at E15. 5 but not yet at E13.5 ( Fig. 2 A, green, and B, green columns). We did not observe a significant alteration in the radial thickness of the progenitorcontaining layers at any of the stages analyzed ( Fig. 2 A and B (20), showed that this was indeed the case. Whereas very few, if any, apoptotic cells could be detected in the control brain tissue at any of the stages analyzed, such cells were frequently observed in the SQS-cKO dTE at E13.5 and even more so at E15.5, and in the SQS-cKO DiE at E12.5 and, massively, at E13.5. Most of the apoptotic cells were found in the NL and only a minor proportion of them in the progenitor layers ( Fig. 2 A, red). We did not observe any significant decrease in ventricular and abventricular mitotic (phosphohistone 3-positive) cells in the SQS-cKO E13.5 dTE and DiE (data not shown). We therefore conclude that the reduction in radial thickness of the NL in the SQS-cKO E15.5 dTE and E13.5 DiE primarily reflected apoptosis of newborn neurons rather than impaired neurogenesis.
Immunostaining for nestin, a marker of VZ progenitors (i.e., neuroepithelial cells and radial glial cells) (21) , revealed a similar pattern for control and SQS-cKO E13.5 dTE and DiE, with radial fibers extending all of the way to the basal lamina (Fig. S2) . This, together with the unaltered thickness of the progenitor layers and the apoptosis predominantly in the NL (Fig. 2 ), was consistent with the notion that newborn neurons rather than neural progenitors were affected by the conditional SQS inactivation.
Full-Length SQS Protein Levels in the Embryonic Brain Are Reduced
Upon Conditional Ablation of SQS Exon 5. Given that the primary target cells for conditional ablation (cKO) of the SQS exon 5 by nestin-Cre were the VZ progenitors, the preferential apoptosis of newborn neurons (Fig. 2) called for a verification of this ablation and for an analysis of the SQS protein levels in progenitors vs. neurons. As described in detail in SI Text, analysis of the E13.5 dTE and DiE revealed that the specific nestin-Cre expression in the VZ (Fig. S1 A) indeed resulted in (i) the ablation of SQS exon 5, as revealed by genomic PCR (Fig. S1B,  a) ; (ii) the dramatic reduction in the full-length, exon 5-containing SQS mRNA, as revealed by RT-PCR (Fig. S1B, b) ; (iii) a massive decrease in the full-length SQS protein, as revealed by immunoblotting (Fig. S1B, c and d) ; and (iv) a marked reduction of SQS immunoreactivity in the VZ and, although to a lesser extent, in the NL, as revealed by immunofluorescence (Fig.  S1C ). In fact, the level of SQS immunoreactivity in neurons was found to be higher than that in VZ progenitors (Fig. S1C) . Thus, the cells in which SQS levels were most reduced (i.e., the VZ progenitors) were largely protected from apoptosis, whereas their progeny, the neurons, was not.
Cholesterol Level in SQS-cKO Embryonic Brain Is Only Mildly Reduced.
We next investigated the consequences of SQS cKO for brain cholesterol levels, that is, the sum of endogenously synthesized cholesterol and that taken up from external sources, such as the ventricular fluid (22) and the blood. Total lipids including cholesterol were extracted from a pool of E13.5 dTE plus DiE and analyzed by TLC and mass spectrometry (see further below). SQS-cKO brain tissue showed a small but significant decrease in the ratio of cholesterol over phosphatidylcholine compared with control ( Fig. 3 A and B) .
Lipid Droplets Containing Triacylglycerides with Unsaturated Fatty
Acyl Chains Are Enriched in SQS-cKO Embryonic Brain. Concomitant with the decrease in cholesterol, TLC revealed an increase in triacylglycerides (TAGs), and perhaps in cholesterol esters, in SQS-cKO brain tissue (Fig. 3A) . TAGs and cholesterol esters are known to be stored intracellularly in lipid droplets (23) (24) (25) (26) . Immunofluorescence for adipocyte differentiation-related protein (ADRP), a lipid droplet marker (27) , showed an increase in lipid droplets in both the progenitor layers and NL of E13.5 SQS-cKO brain tissue compared with control, which was particularly striking for the DiE (Fig. 4A ). On conventional EM analysis, these lipid droplets were found to be unusually osmiophilic (Fig. 4C) , suggestive of an abundance of carbon double bonds (28) . Indeed, the analysis of total lipid extracts by shotgun mass spectrometry showed that the amount of total TAGs relative to the total content of phosphatidylcholines (PCs) was increased 2-fold in the pool of SQS-cKO E13.5 dTE plus DiE as compared with control (Fig. 4B) . Interestingly, this was largely due to an increase in the abundance of TAG species with unsaturated fatty acyl moieties, in particular those with more than 3 double bonds per TAG molecule (Fig. 4B, Fig. S3 , and Table S2 ). In addition, mass spectrometry corroborated the small reduction in cholesterol and the increase in cholesterol esters observed by TLC (Fig. S3) .
SQS-Ablated VZ Progenitors Induce VEGF Expression, Resulting in
Increased Angiogenesis. The greater abundance of lipid droplets in the SQS-cKO brain tissue raised the possibility that the lack of cholesterol biosynthesis in VZ progenitors and the neurons derived therefrom upon SQS exon 5 cKO was compensated by increased uptake of lipoproteins carrying cholesterol and other lipids. VZ progenitors, which were found to be much less susceptible to the SQS-cKO-induced apoptosis than neurons (Fig. 2 A) , line the ventricular lumen (in contrast to neurons), which is known to contain lipoproteins (22) . We therefore explored such a possible compensation by immunostaining for megalin, low-density lipoprotein receptor-related protein known to be expressed at the ventricular surface of VZ progenitors (29-31). However, megalin immunoreactivity, which showed the characteristic concentration at the ventricular side of the VZ, did not seem to be strikingly different in abundance in the SQS-cKO E13.5 dTE and DiE when compared with the control (data not shown). Another possible way of compensating for the lack of cholesterol biosynthesis would be increased lipoprotein uptake from the blood. We therefore examined the blood vessels in the E12.5 and E13.5 control and SQS-cKO brain by immunostaining for platelet endothelial cell adhesion molecule-1 (PECAM-1), a membrane protein found at the surface of endothelial cells (32) . This showed that SQS cKO resulted in an increase in blood vessels, which was most obvious for the E13.5 DiE (Fig. 5A) . Specifically, quantification on cryosections revealed an increase, in the E13.5 SQS-cKO dTE and DiE as compared with control, in the VZ area occupied by PECAM-1-stained blood vessels. This increase was observed irrespective of whether blood vessel area in the VZ was expressed per total VZ area (Fig. 5C, Left) or per ventricular (apical) surface (Fig. 5C, Middle Right) . By contrast, the E13.5 SQS-cKO dTE and DiE did not exhibit an increase, relative to control brain, in the blood vessel area in the NL when expressed per ventricular (apical) surface (Fig. 5C,  Right) . We did observe an increase in blood vessel area in the NL of the E13.5 SQS-cKO DiE compared with control when expressed per total NL area (Fig. 5C , Middle Left), but this increase reflected the reduced thickness of the NL upon SQS cKO (Fig.  5A , see also Fig. 2 ) rather than a true increase in angiogenesis.
To explore the underlying cause of the increase in blood vessels in the SQS-cKO brain, we performed in situ hybridization for VEGF mRNA, the main angiogenic factor in the developing brain (33) (34) (35) . Remarkably, we observed a marked increase in VEGF mRNA expression in the E12.5 and E13.5 SQS-cKO dTE and DiE, which was largely confined to VZ (Fig. 5B) . On immunostaining for VEGF protein, whereas very little, if any, immunoreactivity could be detected in the E13.5 control DiE, we observed an increased VEGF immunoreactivity in the E13.5 SQS-cKO DiE (Fig. S4) . This VEGF immunostaining, consistent with the results of in situ hybridization (Fig. 5B) and previous observations at earlier developmental stages (36) , was predominantly detected in the VZ (Fig. S4) . We conclude that cKO of cholesterol biosynthesis in VZ progenitors causes an upregulation of VEGF expression in these cells, which presumably underlies the increased angiogenesis observed primarily in the VZ.
Increased VEGF Expression in SQS-Ablated VZ Progenitors Occurs via
a HIF-1-Independent Pathway. To further address the molecular mechanism underlying the upregulation of VEGF expression in VZ progenitors upon cKO of cholesterol biosynthesis, we examined the levels of hypoxia-inducible factor-1 (HIF-1), a major inducer of VEGF expression (37, 38) . Remarkably, HIF-1␣ levels in the E13.5 SQS-cKO DiE were essentially the same as in control (Fig. 5D ). Similarly, the mRNA level of the glucose transporter Glut1, a target gene whose expression is known to be stimulated by HIF-1 (38, 39) , was also unaltered in the E13.5 DiE upon SQS cKO (Fig. 5E ). Taken together, these data indicate that the upregulation of VEGF expression in VZ progenitors upon cKO of cholesterol biosynthesis occurs via a HIF-1-independent pathway.
Discussion
A key finding of the present study is the demonstration that neural stem cells are able to compensate for the ablation of endogenous cholesterol biosynthesis by upregulating VEGF expression, thereby promoting angiogenesis into the neurogenic niche and consequently increasing their supply with cholesterolbearing lipoproteins. It has been known that statins, which inhibit 3-hydroxy-3-methylglutaryl coenzyme A reductase and thus the biosynthesis of isoprenoids including cholesterol, can cause an upregulation of VEGF and promote angiogenesis, but these effects have generally been thought to be independent of the cholesterol-lowering function of statins and to involve geranylated proteins as well as nitric oxide and Akt signaling (40) (41) (42) (43) (44) . In contrast, our approach was to selectively ablate the biosynthesis of cholesterol (rather than that of all isoprenoids), and so the present study establishes a direct link between intracellular cholesterol levels, VEGF expression, and angiogenesis and, importantly, has addressed the relevance of this link for neural stem cells and the development of the mammalian brain.
The increase in lipid droplets observed for the neural stem and progenitor cells as well as their neuronal progeny in the SQScKO brain presumably reflected an increased uptake of cholesterol-bearing lipoproteins into these cells. The latter was likely due, at least in part, to the elevated lipoprotein supply resulting from the increased angiogenesis, although in the case of the VZ progenitors an increased uptake from the ventricular fluid may also have occurred. Besides cholesterol ester, lipoproteins are known to contain other lipids with unsaturated fatty acyl chains (45) , which would explain the increased abundance in the SQS-cKO brain of lipid droplets containing TAGs with unsaturated fatty acyl chains.
Considering that SQS was ablated in neural stem and progenitor cells, the preferential apoptosis of newborn neurons, resulting in a dramatically smaller brain and lethality at birth, is remarkable. [Although the particular nestin-Cre line we used has been reported to result in the ablation of floxed genes selectively in the nervous system (17), we cannot exclude phenotypic effects due to SQS ablation outside the CNS (e.g., in the peripheral nervous system).] This is even more so the case given that it was previously observed that neurons in the adult cerebellum do not require endogenous cholesterol biosynthesis (46) . Possible explanations as to why SQS exon 5-deficient neurons were so much more sensitive to the lack of endogenous cholesterol biosynthesis than their own mutant progenitors include the following. First, there was no striking upregulation of VEGF expression and no marked increase in angiogenesis in the NL as there was in the VZ, and so compensation via increased lipoprotein supply from the blood circulation may have occurred to a lesser extent in the case of neurons than VZ progenitors. (This explanation is not necessarily contradicted by the lipid droplet increase in the NL, because this could reflect inheritance of these organelles from progenitors.) Second, in contrast to VZ progenitors, neurons do not have direct access to the ventricular fluid, which is known to contain cholesterol-bearing lipoproteins (22) , and hence are deprived of this other route of compensation. Third, given the fact that neurons form extensive processes, which implies plasma membrane growth, they may have a greater need for cholesterol than VZ progenitors, in particular during development. Fourth, considering the marked increase in lipid droplets, neurons may be more sensitive to lipotoxicity (47) than VZ progenitors.
In conclusion, the neural stem cells of the mammalian brain are endowed with 2 specific properties that enable them to avoid the detrimental consequences of a lack of endogenous cholesterol. First, by lining the lumen of a cavity filled with lipoproteins (i.e., the neural tube), they are privileged to access a unique source of cholesterol. Second, they can signal to increase their supply with lipoproteins from the blood circulation. As shown in the present study, these 2 features of neural stem cells provide an effective means of compensation that is lacking in their neuronal progeny, resulting in the massive depletion of neurons.
Materials and Methods
Animals. Inactivation of the squalene synthase gene (SQS/Fdft1) in VZ cells was obtained by crossing SQS flox/wt /nestin-Cre ϩ/Ϫ mice with SQS flox/flox mice (16, 17) . Embryos were genotyped by PCR. SQS flox/flox /nestin-Cre Ϫ/Ϫ or SQS flox/wt /nestinCre Ϫ/Ϫ mice were used as controls, SQS flox/wt /nestin-Cre ϩ/Ϫ mice as heterozygous animals, and SQS flox/flox /nestin-Cre ϩ/Ϫ mice as SQS-cKO animals. All experiments were performed in accordance with German animal welfare legislation.
